Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 96.50
Bid: 93.00
Ask: 100.00
Change: 0.00 (0.00%)
Spread: 7.00 (7.527%)
Open: 96.50
High: 96.50
Low: 96.50
Prev. Close: 96.50
UAV Live PriceLast checked at -
Unicorn AIM VCT is an Investment Trust

To provide shareholders with an attractive return from a diversified portfolio, predominantly invested in the shares of AIM quoted companies by maintaining dividend distributions to shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

18 Feb 2008 11:04

Unicorn AIM VCT plc

Interim Management Statement

For the period from 1 October 2007 to 31 January 2008

Introduction

The Company has prepared this Interim Management Statement (IMS) in accordance with the Disclosure and Transparency Rules of the UK Listing Authority. The IMS covers the four month period ended 31 January 2008, together with relevant information up to the date of publication.

Investment Objective

The objective of the Company is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maximising the stream of dividend distributions to Shareholders from the income and capital gains generated by the portfolio.

It is also the objective that the Company should continue to qualify as a Venture Capital Trust, so that Shareholders benefit from the taxation advantages that this brings. To achieve this at least 70% of the Company's total assets are to be invested in qualifying investments of which 30% by value must be in ordinary shares carrying no preferential rights to dividends or return of capital and no rights to redemption.

Performance

The period under review has been a difficult one for UK equity markets generally as investors became increasingly concerned about the economic outlook. Smaller companies, as is often the case, were hardest hit due to their inherent lack of liquidity. As a result, the share prices of smaller quoted companies have been under considerable pressure. Since the start of October 2007, the FTSE AIM Index has fallen by over 13%.

Against this backdrop, the Company struggled to make progress and performance was particularly impacted in the Ordinary Share Fund and in the Series 2 (S2) Share Fund by a small number of profit warnings. In the Ordinary Share Fund four investee companies disappointed, with their share price falls collectively accounting for over 40% of the total decline recorded in the period. The S2 Share Fund had relatively large weightings in two of these companies and performance was similarly impacted as a result.

The Net Asset Value (NAV) of the Ordinary Share Fund fell from 89.6p to 71.7p. No dividends were paid or declared during the period under review.

The NAV of the S2 Share Fund fell from 113.8p to 89.5p. A dividend of 5.0p per share was paid to holders of S2 shares during the period.

The NAV of the S3 Share Fund fell from 92.3p to 85.6p. No dividends were paid or declared during the period under review.

Material Transactions

During the period under review, the Ordinary Share Fund made two new qualifying investments into Snacktime and Tracsis at a total cost of ‚£480,000. The Fund's investment in Glisten was reduced, whilst the remaining holding in AssetCo was sold. Tellings Golden Miller was the subject of a successful takeover approach. In total, ‚£984,000 was raised from disposals. Over the four month period, the Fund bought back 219,370 shares at an average price of 70.3p per share.

The S2 Share Fund made three new qualifying investments into Melorio, Snacktime and Tracsis at a total cost of ‚£768,000. Holdings in Abcam and Zetar were reduced. In the non-qualifying portfolio the Fund's entire holding in the Unicorn Free Spirit Fund was sold, whilst positions in the Unicorn Mastertrust Fund and the Unicorn UK Smaller Companies Fund were reduced. In total, ‚£1.44 million was raised from disposals. Over the four month period, the Fund bought back 199,827 shares at an average price of 86.5p per share.

The S3 Share Fund made four new qualifying investments into Animalcare Group, Melorio, Snacktime and Tracsis at a total cost of ‚£723,000.

Top 10 Equity Holdings at 31 January 2008

Ordinary Fund Percentage of Fund Glisten 12.5% Unicorn Free Spirit Fund 9.6% Maxima Holdings 6.2% Mears Group 5.5% Zetar 4.8% Supporta 4.5% Mattioli Woods 4.5% Abcam 4.3% Xpertise Group 3.5% Prologic 2.9% S2 Fund Percentage of Fund Unicorn Mastertrust Fund 12.3% Unicorn UK Smaller Companies Fund 11.0% Mattioli Woods 7.5% Zetar 7.2% Maxima Holdings 6.3% Cohort 5.2% Abcam 5.1% Driver Group 3.2% Amber Taverns 3.8% Melorio 2.9% S3 Fund Percentage of Fund Unicorn Outstanding British Companies 10.3% Fund Unicorn Mastertrust Fund 9.6% Unicorn Free Spirit Fund 9.6% Unicorn UK Smaller Companies Fund 9.1% Unicorn UK Income Fund 8.7% Animalcare Group 4.8% Snacktime 4.5% Melorio 4.6% Tracsis 3.5% Material Events

Other than described above, there were no material events during the period from 1 October 2007 to 31 January 2008.

UNICORN AIM VCT PLC
Date   Source Headline
7th Jun 20247:00 amRNSNet Asset Value(s)
23rd May 20247:00 amRNSHalf-year Report
8th May 20249:47 amRNSNet Asset Value(s)
8th Apr 20241:46 pmRNSNet Asset Value(s)
2nd Apr 202410:46 amRNSTotal Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 202412:00 pmRNSDirector/PDMR Shareholding
11th Mar 202411:59 amRNSTotal Voting Rights
11th Mar 202411:57 amRNSIssue of Equity
7th Mar 202411:34 amRNSNet Asset Value(s)
1st Mar 202410:54 amRNSTotal Voting Rights
15th Feb 20244:30 pmRNSOffer for Subscription Update
14th Feb 20241:36 pmRNSDirector/PDMR Shareholding
14th Feb 202410:23 amRNSIssue of Equity
8th Feb 20243:47 pmRNSOffer for Subscription - Update
7th Feb 20245:43 pmRNSResult of AGM
5th Feb 20243:37 pmRNSNet Asset Value(s)
1st Feb 20242:53 pmRNSInterim Management Statement
26th Jan 202411:47 amRNSOffer for Subscription and Issue of Prospectus
11th Jan 20247:00 amRNSDividend Declaration
9th Jan 202410:39 amRNSNet Asset Value(s)
20th Dec 20233:06 pmRNSDirector Declaration
8th Dec 20237:00 amRNSFinal Results
6th Dec 20233:47 pmRNSNet Asset Value(s)
28th Nov 202310:00 amRNSIntention to launch an Offer
6th Nov 20234:48 pmRNSNet Asset Value(s)
17th Oct 20235:04 pmRNSNet Asset Value(s)
2nd Oct 20239:19 amRNSTotal Voting Rights
25th Sep 20239:18 amRNSTransaction in Own Shares
7th Sep 202311:40 amRNSNet Asset Value(s)
1st Sep 202311:39 amRNSTotal Voting Rights
25th Aug 20239:16 amRNSTransaction in Own Shares
14th Aug 202312:42 pmRNSDirector/PDMR Shareholding
11th Aug 20231:47 pmRNSIssue of Equity under Dividend Reinvestment Scheme
4th Aug 202310:57 amRNSNet Asset Value(s)
1st Aug 202310:19 amRNSTotal Voting Rights
19th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20239:12 amRNSNet Asset Value(s)
3rd Jul 202312:23 pmRNSTotal Voting Rights
9th Jun 20234:11 pmRNSTransaction in Own Shares
6th Jun 20232:18 pmRNSHolding(s) in Company
5th Jun 20234:43 pmRNSNet Asset Value(s)
31st May 20237:00 amRNSHalf-year Report
5th May 20239:20 amRNSNet Asset Value(s)
6th Apr 202310:53 amRNSNet Asset Value(s)
3rd Apr 202310:25 amRNSTotal Voting Rights
10th Mar 20234:32 pmRNSTransaction in Own Shares
3rd Mar 20235:36 pmRNSNet Asset Value(s)
1st Mar 20239:52 amRNSTotal Voting Rights
22nd Feb 20234:04 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.